Kronos Bio, Inc. Profile Avatar - Palmy Investing

Kronos Bio, Inc.

Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks th…

Biotechnology
US, San Mateo [HQ]

Insiders

Transactions

Track non-derivative insider transactions.
i = Indirect d = Direct cs = Common Stock
Reported Owner(s) Position Now Transaction Date Type Position Change Extra
Statistics
Sample Size: 0 Transactions
Sale (S)
0
0.00%
Buy (P)
0
0.00%
100.00%
Other Ownership

Individuals

We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture: